Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Therapyx will develop and manufacture the IL-12-containing microspheres in the vaccine called GneX12.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

XTalks

NOVEMBER 23, 2023

Undeclared Allergens in Snack Foods — The UK In the UK, several snack foods were recalled due to the presence of undeclared allergens , posing serious risks to individuals with allergies. The reasons for these recalls varied, but the most common cause was the omission of priority allergens on labeling.

Contamination 103

Contamination Regulation Bacterium Allergies 103

XTalks

NOVEMBER 6, 2020

Related: Red Meat Allergy Test Gets FDA Clearance. “We DNA vaccines designed using the platform consist of a combination of an advanced gene expression plasmid (pDNA) with gene(s) of interest, and a probiotic bacterium to deliver the vaccine directly to the gut, where it binds to intestinal epithelial cells.

Clinical Trials 75

Clinical Trials Clinical Trials Vaccination Vaccine 75

XTalks

AUGUST 2, 2023

It contains the antiviral medications nirmatrelvir and ritonavir. It works by containing lymphocytes within the lymph nodes , preventing them from entering the central nervous system via the blood-brain barrier and causing an autoimmune reaction that destroys myelin on neurons. Pfizer’s total global revenue from Paxlovid was $18.93

Sales 98

Sales Manufacturing FDA Approval Life Science 98